While research in this area is limited, further work to elucidate how psychedelics may best contribute to scientific creativity enhancement is warranted.

Different psilocybin churches may be united by this common process of sacred sensemaking.

Improved relationships, reduced loneliness, stronger therapeutic alliances.

There was disparity between consumer preferences and guidelines ... concerning consumer agency; consumption alongside others, and carers who had consumed psychedelics themselves.

Religious leaders are beginning to speak out publicly in support of careful use of these drugs, and some are training to become “psychedelic chaplains” to work alongside mental health professionals administering these drugs.

We review historical and modern approaches to the use of ketamine with psychotherapy.

Positive data demonstrating the potential of psilocybin therapy in anorexia nervosa and severe treatment-resistant depression.

This is an interesting study exploring the ongoing question how important it is for psychedelic guides to have had their own personal experience of these medicines.

What will psychedelic-assisted therapy look like when it becomes available? This is a hot debate within the psychedelics field.

The majority of the patients taking part in the psychedelic group therapy suffered from chronic complex post-traumatic stress disorder

Additional research on individual differences in perceptions of ketamine and varied treatments for depression seems warranted.

There were no serious AEs related to psilocybin and LSD administration. Most AEs were expected, manageable and transient.

These data are among the first to establish a strong relationship between personal mindfulness practice, recreational psychedelic use, and overall psychological wellbeing in a naturalistic framework

These findings are consistent with reports that hallucinogen use may lead to shifts in personality as well as multiple cognitive domains.

The evaluated evidence suggests positive effects of psychedelic-assisted therapies for symptom control in patients diagnosed with serious illness.

The renewed interest in psychedelics for select mental disorders ... provides the impetus to characterize HPPD in its frequency, risk and protective factors, key characteristics ...

The results confirm psilocybin mushrooms are a relatively safe drug, with serious incidents rare and short lasting.